DMAADrugs Made In America Acquisition Corp.
10.61USD+0.09%Mkt Cap: 257.58M USDP/E: 53.05Last update: 2026-05-26
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business …
Industry Peers
Shell CompaniesIndicators:|
Key Statistics
Company
Market Cap257.58M USD
Enterprise Value356.89M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)5.94M USD
Revenue/Share—
Last Price10.61 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryUS
SectorFinancial Services
IndustryShell Companies
ISIN—
Valuation
P/E (Trailing)53.05
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-49.30
EPS (TTM)0.20
EPS (Forward)—
52W Range
10.12100% of range10.61
52W High10.61 USD
52W Low10.12 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE2.55%
ROA2.48%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-539.19K USD
CapEx (TTM)—
FCF Margin—
FCF Yield-0.59%
Net Debt-6.14K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio0.03
Quick Ratio0.02
Book Value/Sh-0.2150 USD
Cash/Share0.0000 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.24.28M
Float27.31M
Insiders18.49%
Institutions98.23%
Short Interest
Short Ratio0.4d
Short % Float0.36%
Short % Out.0.31%
Shares Short103.81K
Short (prev mo.)17.25K
Technical
SMA 5010.54 (+0.7%)
SMA 20010.39 (+2.1%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)181.51K
Avg Vol (10d)5.89K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—